Summary Information:
Kintara Therapeutics Inc. Common Stock
NASDAQ:KTRA


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Kintara Therapeutics Inc. Common Stock
Exchange: NASDAQ
Symbol: KTRA
SEC CIK: 0001498382
Phone: (858) 350-4364
12707 HIGH BLUFF DR., SUITE 200
SAN DIEGO CA 92130

CEO: Saiid Zarrabian
Price when page updated: 0.3502 Date: 2023-11-30
Company Website:
www.kintara.com

_Description: Kintara Therapeutics, Inc. operates as a clinical and commercial stage drug development company with a focus on the treatment of cancer. The Company focuses on identifying clinical and commercial-stage compounds and establishing a scientific rationale for development in modern orphan drug indications. Kintara Therapeutics serves customers worldwide.

IPO YEAR:

Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
1186410.00
Beta:
1.0980432145249
52 Week High:
3.35
52 Week Low:
0.5
52 Week Change:
-0.5658394160583942
Short Interest:

Short Date:

Shares Outstanding:
48535338
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
14 Nov 2022
Float:
0
return on Equity:
-
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$22.62
ttmEPS:
0
Revenue:
$0.00
Gross Profit:

Cash:

Debt:

Institution Percent:
4.70%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
1.20%
Return on Assets:
-146.10%
Return on Capital:

Profit Margin:
-
Price to Sales:
-
Price To Book:
-
Short Ratio:
0.32
PE Ratio:
0
Employees:
2019
1Y Guesstimate
2.361:21.0:6




__The following are links to various summary and news pages for
__Kintara Therapeutics Inc. Common Stock [ KTRA ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30